ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-11G17460
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetes Treatment Devices Market Research Report 2024
BUY CHAPTERS

Global Diabetes Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11G17460
Report
October 2025
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Novo Nordisk
Lilly
Ganlee
Insulet Corp
Tandem Diabetes Care
Valeritas
SOOIL
Lepu Medical

Diabetes Treatment Devices Market

The global Diabetes Treatment Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Type I Diabetes accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Diabetes Treatment Devices leading manufacturers including Medtronic, Roche, Novo Nordisk, Sanofi, Lilly, Ganlee, Insulet Corp, Tandem Diabetes Care, Valeritas, SOOIL, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Diabetes Treatment Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Diabetes Treatment Devices Market Report

Report Metric Details
Report Name Diabetes Treatment Devices Market
Segment by Type
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
Segment by Application
  • Type I Diabetes
  • Type II Diabetes
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Roche, Novo Nordisk, Sanofi, Lilly, Ganlee, Insulet Corp, Tandem Diabetes Care, Valeritas, SOOIL, Lepu Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Diabetes Treatment Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Diabetes Treatment Devices Market report?

Ans: The main players in the Diabetes Treatment Devices Market are Medtronic, Roche, Novo Nordisk, Sanofi, Lilly, Ganlee, Insulet Corp, Tandem Diabetes Care, Valeritas, SOOIL, Lepu Medical

What are the Application segmentation covered in the Diabetes Treatment Devices Market report?

Ans: The Applications covered in the Diabetes Treatment Devices Market report are Type I Diabetes, Type II Diabetes

What are the Type segmentation covered in the Diabetes Treatment Devices Market report?

Ans: The Types covered in the Diabetes Treatment Devices Market report are Insulin Syringes, Insulin Pens, Insulin Pumps

1 Study Coverage
1.1 Introduction to Diabetes Treatment Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Diabetes Treatment Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Insulin Syringes
1.2.3 Insulin Pens
1.2.4 Insulin Pumps
1.3 Market Segmentation by Application
1.3.1 Global Diabetes Treatment Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Diabetes Treatment Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Diabetes Treatment Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Diabetes Treatment Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Diabetes Treatment Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Diabetes Treatment Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Diabetes Treatment Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Insulin Syringes Market Size by Manufacturers
3.5.2 Insulin Pens Market Size by Manufacturers
3.5.3 Insulin Pumps Market Size by Manufacturers
3.6 Global Diabetes Treatment Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Diabetes Treatment Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Diabetes Treatment Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Diabetes Treatment Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Diabetes Treatment Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Diabetes Treatment Devices Sales and Revenue by Type (2020-2031)
6.4 North America Diabetes Treatment Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Diabetes Treatment Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Diabetes Treatment Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Diabetes Treatment Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Diabetes Treatment Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Diabetes Treatment Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Diabetes Treatment Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Diabetes Treatment Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Diabetes Treatment Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Diabetes Treatment Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Diabetes Treatment Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Diabetes Treatment Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Diabetes Treatment Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Diabetes Treatment Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.1.4 Medtronic Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Diabetes Treatment Devices Sales by Product in 2024
11.1.6 Medtronic Diabetes Treatment Devices Sales by Application in 2024
11.1.7 Medtronic Diabetes Treatment Devices Sales by Geographic Area in 2024
11.1.8 Medtronic Diabetes Treatment Devices SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Business Overview
11.2.3 Roche Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.2.4 Roche Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Roche Diabetes Treatment Devices Sales by Product in 2024
11.2.6 Roche Diabetes Treatment Devices Sales by Application in 2024
11.2.7 Roche Diabetes Treatment Devices Sales by Geographic Area in 2024
11.2.8 Roche Diabetes Treatment Devices SWOT Analysis
11.2.9 Roche Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Corporation Information
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.3.4 Novo Nordisk Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Novo Nordisk Diabetes Treatment Devices Sales by Product in 2024
11.3.6 Novo Nordisk Diabetes Treatment Devices Sales by Application in 2024
11.3.7 Novo Nordisk Diabetes Treatment Devices Sales by Geographic Area in 2024
11.3.8 Novo Nordisk Diabetes Treatment Devices SWOT Analysis
11.3.9 Novo Nordisk Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.4.4 Sanofi Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sanofi Diabetes Treatment Devices Sales by Product in 2024
11.4.6 Sanofi Diabetes Treatment Devices Sales by Application in 2024
11.4.7 Sanofi Diabetes Treatment Devices Sales by Geographic Area in 2024
11.4.8 Sanofi Diabetes Treatment Devices SWOT Analysis
11.4.9 Sanofi Recent Developments
11.5 Lilly
11.5.1 Lilly Corporation Information
11.5.2 Lilly Business Overview
11.5.3 Lilly Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.5.4 Lilly Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Lilly Diabetes Treatment Devices Sales by Product in 2024
11.5.6 Lilly Diabetes Treatment Devices Sales by Application in 2024
11.5.7 Lilly Diabetes Treatment Devices Sales by Geographic Area in 2024
11.5.8 Lilly Diabetes Treatment Devices SWOT Analysis
11.5.9 Lilly Recent Developments
11.6 Ganlee
11.6.1 Ganlee Corporation Information
11.6.2 Ganlee Business Overview
11.6.3 Ganlee Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.6.4 Ganlee Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Ganlee Recent Developments
11.7 Insulet Corp
11.7.1 Insulet Corp Corporation Information
11.7.2 Insulet Corp Business Overview
11.7.3 Insulet Corp Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.7.4 Insulet Corp Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Insulet Corp Recent Developments
11.8 Tandem Diabetes Care
11.8.1 Tandem Diabetes Care Corporation Information
11.8.2 Tandem Diabetes Care Business Overview
11.8.3 Tandem Diabetes Care Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.8.4 Tandem Diabetes Care Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Tandem Diabetes Care Recent Developments
11.9 Valeritas
11.9.1 Valeritas Corporation Information
11.9.2 Valeritas Business Overview
11.9.3 Valeritas Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.9.4 Valeritas Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Valeritas Recent Developments
11.10 SOOIL
11.10.1 SOOIL Corporation Information
11.10.2 SOOIL Business Overview
11.10.3 SOOIL Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.10.4 SOOIL Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 SOOIL Recent Developments
11.11 Lepu Medical
11.11.1 Lepu Medical Corporation Information
11.11.2 Lepu Medical Business Overview
11.11.3 Lepu Medical Diabetes Treatment Devices Product Models, Descriptions and Specifications
11.11.4 Lepu Medical Diabetes Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Lepu Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Diabetes Treatment Devices Industry Chain
12.2 Diabetes Treatment Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Diabetes Treatment Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Diabetes Treatment Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Diabetes Treatment Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Diabetes Treatment Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Roche
Novo Nordisk
Lilly
Ganlee
Insulet Corp
Tandem Diabetes Care
Valeritas
SOOIL
Lepu Medical
List of Tables
 Table 1. Global Diabetes Treatment Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Diabetes Treatment Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Diabetes Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Diabetes Treatment Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Diabetes Treatment Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Diabetes Treatment Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Diabetes Treatment Devices Sales by Region (2020-2025) & (K Units)
 Table 8. Global Diabetes Treatment Devices Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Diabetes Treatment Devices Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Diabetes Treatment Devices Sales Share by Manufacturers (2020-2025)
 Table 12. Global Diabetes Treatment Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Diabetes Treatment Devices Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Diabetes Treatment Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Treatment Devices as of 2024)
 Table 16. Global Diabetes Treatment Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Diabetes Treatment Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Diabetes Treatment Devices Manufacturing Base and Headquarters
 Table 19. Global Diabetes Treatment Devices Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Diabetes Treatment Devices Sales by Type (2020-2025) & (K Units)
 Table 23. Global Diabetes Treatment Devices Sales by Type (2026-2031) & (K Units)
 Table 24. Global Diabetes Treatment Devices Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Diabetes Treatment Devices Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Diabetes Treatment Devices ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Diabetes Treatment Devices Sales by Application (2020-2025) & (K Units)
 Table 29. Global Diabetes Treatment Devices Sales by Application (2026-2031) & (K Units)
 Table 30. Diabetes Treatment Devices High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Diabetes Treatment Devices Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Diabetes Treatment Devices Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Diabetes Treatment Devices ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Diabetes Treatment Devices Growth Accelerators and Market Barriers
 Table 37. North America Diabetes Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Diabetes Treatment Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Diabetes Treatment Devices Growth Accelerators and Market Barriers
 Table 40. Europe Diabetes Treatment Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Diabetes Treatment Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Diabetes Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Diabetes Treatment Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Diabetes Treatment Devices Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Diabetes Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Diabetes Treatment Devices Investment Opportunities and Key Challenges
 Table 47. Central and South America Diabetes Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Diabetes Treatment Devices Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Diabetes Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Medtronic Corporation Information
 Table 51. Medtronic Description and Major Businesses
 Table 52. Medtronic Product Models, Descriptions and Specifications
 Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Medtronic Sales Value Proportion by Product in 2024
 Table 55. Medtronic Sales Value Proportion by Application in 2024
 Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 57. Medtronic Diabetes Treatment Devices SWOT Analysis
 Table 58. Medtronic Recent Developments
 Table 59. Roche Corporation Information
 Table 60. Roche Description and Major Businesses
 Table 61. Roche Product Models, Descriptions and Specifications
 Table 62. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Roche Sales Value Proportion by Product in 2024
 Table 64. Roche Sales Value Proportion by Application in 2024
 Table 65. Roche Sales Value Proportion by Geographic Area in 2024
 Table 66. Roche Diabetes Treatment Devices SWOT Analysis
 Table 67. Roche Recent Developments
 Table 68. Novo Nordisk Corporation Information
 Table 69. Novo Nordisk Description and Major Businesses
 Table 70. Novo Nordisk Product Models, Descriptions and Specifications
 Table 71. Novo Nordisk Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Novo Nordisk Sales Value Proportion by Product in 2024
 Table 73. Novo Nordisk Sales Value Proportion by Application in 2024
 Table 74. Novo Nordisk Sales Value Proportion by Geographic Area in 2024
 Table 75. Novo Nordisk Diabetes Treatment Devices SWOT Analysis
 Table 76. Novo Nordisk Recent Developments
 Table 77. Sanofi Corporation Information
 Table 78. Sanofi Description and Major Businesses
 Table 79. Sanofi Product Models, Descriptions and Specifications
 Table 80. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Sanofi Sales Value Proportion by Product in 2024
 Table 82. Sanofi Sales Value Proportion by Application in 2024
 Table 83. Sanofi Sales Value Proportion by Geographic Area in 2024
 Table 84. Sanofi Diabetes Treatment Devices SWOT Analysis
 Table 85. Sanofi Recent Developments
 Table 86. Lilly Corporation Information
 Table 87. Lilly Description and Major Businesses
 Table 88. Lilly Product Models, Descriptions and Specifications
 Table 89. Lilly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Lilly Sales Value Proportion by Product in 2024
 Table 91. Lilly Sales Value Proportion by Application in 2024
 Table 92. Lilly Sales Value Proportion by Geographic Area in 2024
 Table 93. Lilly Diabetes Treatment Devices SWOT Analysis
 Table 94. Lilly Recent Developments
 Table 95. Ganlee Corporation Information
 Table 96. Ganlee Description and Major Businesses
 Table 97. Ganlee Product Models, Descriptions and Specifications
 Table 98. Ganlee Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Ganlee Recent Developments
 Table 100. Insulet Corp Corporation Information
 Table 101. Insulet Corp Description and Major Businesses
 Table 102. Insulet Corp Product Models, Descriptions and Specifications
 Table 103. Insulet Corp Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Insulet Corp Recent Developments
 Table 105. Tandem Diabetes Care Corporation Information
 Table 106. Tandem Diabetes Care Description and Major Businesses
 Table 107. Tandem Diabetes Care Product Models, Descriptions and Specifications
 Table 108. Tandem Diabetes Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Tandem Diabetes Care Recent Developments
 Table 110. Valeritas Corporation Information
 Table 111. Valeritas Description and Major Businesses
 Table 112. Valeritas Product Models, Descriptions and Specifications
 Table 113. Valeritas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Valeritas Recent Developments
 Table 115. SOOIL Corporation Information
 Table 116. SOOIL Description and Major Businesses
 Table 117. SOOIL Product Models, Descriptions and Specifications
 Table 118. SOOIL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. SOOIL Recent Developments
 Table 120. Lepu Medical Corporation Information
 Table 121. Lepu Medical Description and Major Businesses
 Table 122. Lepu Medical Product Models, Descriptions and Specifications
 Table 123. Lepu Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Lepu Medical Recent Developments
 Table 125. Key Raw Materials Distribution
 Table 126. Raw Materials Key Suppliers
 Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 128. Milestones in Production Technology Evolution
 Table 129. Distributors List
 Table 130. Market Trends and Market Evolution
 Table 131. Market Drivers and Opportunities
 Table 132. Market Challenges, Risks, and Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Diabetes Treatment Devices Product Picture
 Figure 2. Global Diabetes Treatment Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Insulin Syringes Product Picture
 Figure 4. Insulin Pens Product Picture
 Figure 5. Insulin Pumps Product Picture
 Figure 6. Global Diabetes Treatment Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Type I Diabetes
 Figure 8. Type II Diabetes
 Figure 9. Diabetes Treatment Devices Report Years Considered
 Figure 10. Global Diabetes Treatment Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Diabetes Treatment Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Diabetes Treatment Devices Revenue Market Share by Region (2020-2031)
 Figure 14. Global Diabetes Treatment Devices Sales (2020-2031) & (K Units)
 Figure 15. Global Diabetes Treatment Devices Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Diabetes Treatment Devices Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Diabetes Treatment Devices Sales Volume Market Share in 2024
 Figure 18. Global Diabetes Treatment Devices Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Insulin Syringes Revenue Market Share by Manufacturer in 2024
 Figure 21. Insulin Pens Revenue Market Share by Manufacturer in 2024
 Figure 22. Insulin Pumps Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Diabetes Treatment Devices Sales Market Share by Type (2020-2031)
 Figure 24. Global Diabetes Treatment Devices Revenue Market Share by Type (2020-2031)
 Figure 25. Global Diabetes Treatment Devices Sales Market Share by Application (2020-2031)
 Figure 26. Global Diabetes Treatment Devices Revenue Market Share by Application (2020-2031)
 Figure 27. North America Diabetes Treatment Devices Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Diabetes Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Diabetes Treatment Devices Sales Revenue (US$ Million) in 2024
 Figure 30. North America Diabetes Treatment Devices Sales Volume (K Units) by Type (2020- 2031)
 Figure 31. North America Diabetes Treatment Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Diabetes Treatment Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America Diabetes Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Diabetes Treatment Devices Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Diabetes Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Diabetes Treatment Devices Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Diabetes Treatment Devices Sales Volume (K Units) by Type (2020-2031)
 Figure 41. Europe Diabetes Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Diabetes Treatment Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe Diabetes Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 45. France Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Diabetes Treatment Devices Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Diabetes Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Diabetes Treatment Devices Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Diabetes Treatment Devices Sales Volume (K Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Diabetes Treatment Devices Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Diabetes Treatment Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Diabetes Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 60. India Diabetes Treatment Devices Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Diabetes Treatment Devices Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Diabetes Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Diabetes Treatment Devices Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Diabetes Treatment Devices Sales Volume (K Units) by Type (2021-2031)
 Figure 65. Central and South America Diabetes Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Diabetes Treatment Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America Diabetes Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Diabetes Treatment Devices Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Diabetes Treatment Devices Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Diabetes Treatment Devices Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Diabetes Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Diabetes Treatment Devices Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Diabetes Treatment Devices Sales Volume (K Units) by Type (2021-2031)
 Figure 74. South America Diabetes Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Diabetes Treatment Devices Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Diabetes Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Diabetes Treatment Devices Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Diabetes Treatment Devices Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Diabetes Treatment Devices Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Diabetes Treatment Devices Revenue (2020-2025) & (US$ Million)
 Figure 81. Diabetes Treatment Devices Industry Chain Mapping
 Figure 82. Regional Diabetes Treatment Devices Manufacturing Base Distribution (%)
 Figure 83. Global Diabetes Treatment Devices Production Market Share by Region (2020-2031)
 Figure 84. Diabetes Treatment Devices Production Process
 Figure 85. Regional Diabetes Treatment Devices Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Diabetes Management Medical Devices Market Research Report 2024
Diabetes Devices and Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Home Diabetes Care Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digital Diabetes Tools Market Research Report 2025
Global Blood Glucose Device Market Research Report 2024
Digital Diabetes Device Market
Diabetic Eye Disease Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Care Devices Drugs Market Research Report 2024
Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Sensor Market Research Report 2024
Global Diabetic Injection Instrument Market Research Report 2025
Global Diabetes Testing Kit Market Research Report 2024
Diabetes Management Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Care Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Wearables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Glucose Testing Equipment Market Research Report 2025
Diabetes Management Insulin Pump and Continuous Glucose Monitors CGM Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Diabetes Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glucose Analyzer Device Market Research Report 2025
Global Continuous Blood Glucose Monitoring Devices Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions